ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease.
about
Obesity genotype score and cardiovascular risk in women with type 2 diabetes mellitusRab8-dependent recycling promotes endosomal cholesterol removal in normal and sphingolipidosis cellsDysfunctional High-Density Lipoprotein: An Innovative Target for Proteomics and LipidomicsStructural basis for distinct functions of the naturally occurring Cys mutants of human apolipoprotein A-IApoptotic cell clearance: basic biology and therapeutic potential.New insights into the determination of HDL structure by apolipoproteins: Thematic review series: high density lipoprotein structure, function, and metabolismMolecular mechanisms of cellular cholesterol effluxPhagocytosis of apoptotic cells in homeostasisAmyloidogenic mutations in human apolipoprotein A-I are not necessarily destabilizing - a common mechanism of apolipoprotein A-I misfolding in familial amyloidosis and atherosclerosisOverexpression of steroidogenic acute regulatory protein increases macrophage cholesterol efflux to apolipoprotein AIRole of lipids in spheroidal high density lipoproteinsEthanol induces cholesterol efflux and up-regulates ATP-binding cassette cholesterol transporters in fetal astrocytes.Apoptotic cells trigger a membrane-initiated pathway to increase ABCA1The crystal structure of the C-terminal truncated apolipoprotein A-I sheds new light on amyloid formation by the N-terminal fragment.Structure of spheroidal HDL particles revealed by combined atomistic and coarse-grained simulations.Specific loss of brain ABCA1 increases brain cholesterol uptake and influences neuronal structure and function.Low clusterin levels in high-density lipoprotein associate with insulin resistance, obesity, and dyslipoproteinemia.Tangier disease: epidemiology, pathophysiology, and management.HDL in humans with cardiovascular disease exhibits a proteomic signature.Meta-analyses between 18 candidate genetic markers and overweight/obesityEffects of cholesterol on thermal stability of discoidal high density lipoproteins.Correlation of structural stability with functional remodeling of high-density lipoproteins: the importance of being disordered.Coronary Artery Disease-Associated LIPA Coding Variant rs1051338 Reduces Lysosomal Acid Lipase Levels and Activity in Lysosomes.Myeloperoxidase: an oxidative pathway for generating dysfunctional high-density lipoproteinFatty acid- and cholesterol transporter protein expression along the human intestinal tract.Humans with atherosclerosis have impaired ABCA1 cholesterol efflux and enhanced high-density lipoprotein oxidation by myeloperoxidase.Membrane organization and regulation of cellular cholesterol homeostasis.Modifying apolipoprotein A-I by malondialdehyde, but not by an array of other reactive carbonyls, blocks cholesterol efflux by the ABCA1 pathwayDiabetes reduces the cholesterol exporter ABCA1 in mouse macrophages and kidneysOxidation of apolipoprotein A-I by myeloperoxidase impairs the initial interactions with ABCA1 required for signaling and cholesterol exportActivation of lecithin:cholesterol acyltransferase by HDL ApoA-I central helices.The interplay between size, morphology, stability, and functionality of high-density lipoprotein subclasses.Multimarker screening of oxidative stress in aging.Gene activation regresses atherosclerosis, promotes health, and enhances longevity.ATP-binding membrane cassette transporter A1 (ABCA1): a possible link between inflammation and reverse cholesterol transport.Lipid-bound apolipoproteins in tyrosyl radical-oxidized HDL stabilize ABCA1 like lipid-free apolipoprotein A-IA retained secretory signal peptide mediates high density lipoprotein (HDL) assembly and function of haptoglobin-related protein.Influence of apolipoprotein (Apo) A-I structure on nascent high density lipoprotein (HDL) particle size distributionMacrophage ABCA1 reduces MyD88-dependent Toll-like receptor trafficking to lipid rafts by reduction of lipid raft cholesterol.High-density lipoprotein suppresses the type I interferon response, a family of potent antiviral immunoregulators, in macrophages challenged with lipopolysaccharide.
P2860
Q24633541-4C02004F-3B26-4401-9EBF-D953C2F28E72Q24676084-56E4CFDB-F72F-4082-90D3-EE06C6676F03Q26774903-ADC95700-A3FB-4802-8581-0177E5009542Q26823046-A0F1A67F-2B52-4C76-B93D-27D67B002923Q26825935-A5599618-825D-47BB-A3EF-18852E12F392Q26851804-888F9CD3-0EB9-4411-9F14-A67FDC430561Q27021139-FE1E6132-951A-4DE1-BE1E-A0875E371C52Q28081044-66A27D5B-92CC-433C-AE65-BC544B02601EQ28116206-E02D3C01-0CB4-43C0-8675-95FA98E46853Q28270852-95AF1E0B-D792-42F2-8152-705244433004Q28475955-3C177E08-44CD-4690-9B3D-96D86513D49FQ30273888-01E862B9-526B-4AC2-91B0-92CC300C6E99Q30370661-F4FD251A-F1CD-4719-8779-66F1D19563DCQ30411501-EFECB5B7-4200-430C-B59E-F47424887928Q30481344-05293C34-302A-4D4C-832D-B0615F0AB285Q30486577-69CE88D6-0BF2-4050-B596-E572B6E7D0B7Q30497410-4EA1FC66-A6E4-4E9B-8FB3-F5B6CB5C6B6AQ33402921-0849B9ED-F70B-4B17-BBDB-3CA79B095720Q33544033-F789355B-DEFF-4133-8011-0D1DBDA4F897Q33559160-99402605-EE6A-4157-9A08-991DBD112831Q33577845-F4D013CF-2905-4F6E-97A8-846ADDD6CCA8Q33657079-D7E50AB6-B463-4A0F-83D5-01815CAC3D18Q33727315-8C8326E2-9CAE-41E0-9B66-9297B19E1430Q33729198-7EDB0596-EAF7-4765-B3E3-A4A8330FDEECQ33818527-77EE13BD-DA93-4856-B20A-4D26B70D233EQ33825419-08518D0B-75C4-4C5B-89D4-F02C8F5FE0FDQ33845998-9048B3F5-C900-4B52-B330-1993405FF919Q33897803-E40D5661-7A21-4AD9-9991-A941159814FEQ33901965-52F847DE-5D73-4769-99D7-190C786DB991Q33902023-117EC09D-FDF4-44D8-AF9B-7D23DC75769CQ33937174-0CBABDB0-661D-4DA8-89D6-C37AB65282E3Q33987937-E346B0E0-C9BC-4B39-9F64-684F85712506Q34014251-202D54B0-4BFA-493E-B881-49960B9F8F37Q34020016-80203241-E9C6-4482-A6A9-71292A267E62Q34112680-F4BC27F7-5AF3-4A9C-9262-5B3310FA5986Q34128528-BE0E4E32-6597-4938-BA50-EDDB189E4F70Q34138923-FF121904-8055-45B2-97F9-82DD7645E90AQ34186341-0AAEE0ED-B095-4F57-A31F-F01AB1FF8843Q34188006-EB586A35-29A8-4CAD-9469-9FB227195D34Q34334697-D8A3F2EC-53EC-4308-8162-30EA9E1C4FE7
P2860
ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
ATP-binding cassette transport ...... gainst cardiovascular disease.
@ast
ATP-binding cassette transport ...... gainst cardiovascular disease.
@en
type
label
ATP-binding cassette transport ...... gainst cardiovascular disease.
@ast
ATP-binding cassette transport ...... gainst cardiovascular disease.
@en
prefLabel
ATP-binding cassette transport ...... gainst cardiovascular disease.
@ast
ATP-binding cassette transport ...... gainst cardiovascular disease.
@en
P1476
ATP-binding cassette transport ...... gainst cardiovascular disease.
@en
P2093
Jay W Heinecke
John F Oram
P304
P356
10.1152/PHYSREV.00005.2005
P577
2005-10-01T00:00:00Z